Annual Meeting Report

Publishing Chinese Research: A Look at the Evolving Requirements and Experiences of Editors and Scientists

Abstract

CSE 2020 Virtual Annual Meeting MODERATOR: Erin McMullan KWF Editorial/KWF Consulting Baltimore, Maryland SPEAKERS: Hua (Selin) He Medjaden Hong Kong, China Lei Pei Huazhong University of Science and Technology Wuhan, China Clark Holdsworth LetPub Waltham, Massachusetts REPORTER: Andrea Kunz Society for Immunotherapy of Cancer Milwaukee, Wisconsin The CSE 2020 Annual Meeting session “Publishing Chinese Research: A Look at the Evolving Requirements and Experiences of Editors and Scientists” explained the evolution of the research assessment system in China relative to scientific articles and academic journals, discussed what qualifies an article to be considered “high-quality,” and shared the experiences of medical scientists navigating the research environment in China. Dr Hua (Selin) He opened the session with a look at the evolving research assessment system in China and the roles that are changing in response to its evolution. The system was presented through 3 eras: the Pre-SCI Era (prior to 1990), the SCI Era (1990–2016), and the SCI Plus Era (2016 to present), with “SCI” referring to “Science Citation Index” (aka, Web of Science) focus. During the Pre-SCI Era, administrative officials made all decisions regarding career advancement. Within the SCI Era—particularly from 1990–2010—a focus on Journal Impact Factors (JIF) created a shift of how and where researchers published as it tied directly to their ability to reach the next step in their career paths. It was determined that a researcher needed to publish in a journal with a JIF greater than 5 to receive a research grant, and a journal with a JIF […]

The full article is for members only

Log In to View Full Article